MDPI and ACS Style
Zamboglou, C.; Spohn, S.K.B.; Adebahr, S.; Huber, M.; Kirste, S.; Sprave, T.; Gratzke, C.; Chen, R.C.; Carl, E.G.; Weber, W.A.;
et al. PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial. Cancers 2021, 13, 5795.
https://doi.org/10.3390/cancers13225795
AMA Style
Zamboglou C, Spohn SKB, Adebahr S, Huber M, Kirste S, Sprave T, Gratzke C, Chen RC, Carl EG, Weber WA,
et al. PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial. Cancers. 2021; 13(22):5795.
https://doi.org/10.3390/cancers13225795
Chicago/Turabian Style
Zamboglou, Constantinos, Simon K. B. Spohn, Sonja Adebahr, Maria Huber, Simon Kirste, Tanja Sprave, Christian Gratzke, Ronald C. Chen, Ernst Günther Carl, Wolfgang A. Weber,
and et al. 2021. "PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial" Cancers 13, no. 22: 5795.
https://doi.org/10.3390/cancers13225795